Dr. Isaiah Bercot, MD Psychiatry & Neurology - Psychiatry Medicare: Not Enrolled in Medicare Practice Location: 8695 Yucca St, Arvada, CO 80007 Phone: 720-515-2169 Fax: 720-818-8035 |
Ramona Lorene Reed, MD Psychiatry & Neurology - Psychiatry Medicare: Not Enrolled in Medicare Practice Location: 12497 W 69th Avenue, Arvada, CO 80004 Phone: 303-420-1906 Fax: 303-421-2346 |
Dr. Katalin J Pocsine, M.D. Psychiatry & Neurology - Neurology Medicare: Accepting Medicare Assignments Practice Location: 5730 Ward Rd, Suite 206, Arvada, CO 80002 Phone: 303-424-0559 Fax: 303-424-0205 |
Dr. David R Torres, MD Psychiatry & Neurology - Psychiatry Medicare: Medicare Enrolled Practice Location: 5738 Olde Wadsworth Blvd, Arvada, CO 80002 Phone: 303-426-7766 Fax: 303-423-1677 |
Dr. Karen Louise Horst, MD Psychiatry & Neurology - Psychiatry Medicare: Accepting Medicare Assignments Practice Location: 5601 Olde Wadsworth Blvd, Ste. 200, Arvada, CO 80002 Phone: 720-379-4386 Fax: 720-379-6316 |
Dr. Renee Ann Richker, MD Psychiatry & Neurology - Psychiatry Medicare: Not Enrolled in Medicare Practice Location: 5738 Olde Wadsworth Blvd, Arvada, CO 80002 Phone: 303-425-1011 Fax: 303-279-3985 |
Dr. John R Smolley Jr., MD Psychiatry & Neurology - Psychiatry Medicare: Not Enrolled in Medicare Practice Location: 5738 Olde Wadsworth Blvd, Arvada, CO 80002 Phone: 720-898-9292 Fax: 303-456-9284 |
News Archive
Liquidia Technologies today announced its founder, Dr. Joseph DeSimone, has received the National Institutes of Health (NIH) Director's Pioneer Award. Pioneer Awards are designed to support individual scientists of exceptional creativity who propose pioneering – and possibly transforming – approaches to major challenges in biomedical and behavioral research.
The Global Fund to Fight AIDS, Tuberculosis and Malaria on Thursday in Paris released a report noting that while it disbursed a record $3 billion in 2010, the $1.3 billion shortfall if faces for 2011-2013, "threaten[s] goals to roll back diseases that together claim more than four million lives a year," Agence France-Presse reports.
Nearly two years after COVID-19 was first reported in the United States, the ripple effects of the pandemic are disrupting biomedical research, particularly among young scientists who are reconsidering their career choices as they try to cope with expanded family caregiving responsibilities due to the disease.
In a continuing effort to educate prescribers and patients about the potential risks related to opioid use, the U.S. Food and Drug Administration today announced required class-wide safety labeling changes for immediate-release (IR) opioid pain medications. Among the changes, the FDA is requiring a new boxed warning about the serious risks of misuse, abuse, addiction, overdose and death.
A cure for the common cold isn't in the crystal ball of an infectious diseases researcher and physician at Saint Louis University's Center for Vaccine Development.
› Verified 5 days ago